Cartesian Therapeutics Inc (RNAC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -21,663 | 35,379 | 29,486 | 37,379 | 28,778 |
| Depreciation Amortization | 127 | 912 | 918 | 696 | 352 |
| Accounts receivable | 1,076 | 156 | 2,989 | -14,080 | 2,761 |
| Accounts payable and accrued liabilities | 747 | 92 | -10 | 300 | 18 |
| Other Working Capital | 5,602 | -60,377 | -53,335 | -55,682 | -25,761 |
| Other Operating Activity | 5,346 | -7,793 | 170 | 7,252 | -18,012 |
| Operating Cash Flow | $-8,765 | $-31,631 | $-19,782 | $-24,135 | $-11,864 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 28,254 | -13,801 | -19,501 | 10,000 | 10,000 |
| PPE Investments | -130 | -1,201 | -990 | -554 | -455 |
| Investing Cash Flow | $28,124 | $-15,002 | $-20,491 | $9,446 | $9,545 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 149 | 39,325 | 39,325 | 38,713 | 1,838 |
| Other Financing Activity | 0 | -110 | -110 | -110 | -110 |
| Financing Cash Flow | $149 | $39,215 | $39,215 | $38,603 | $1,728 |
| Exchange Rate Effect | -21 | 20 | 65 | 86 | -29 |
| Beginning Cash Position | 108,038 | 115,436 | 115,436 | 115,436 | 115,436 |
| End Cash Position | 127,525 | 108,038 | 114,443 | 139,436 | 114,816 |
| Net Cash Flow | $19,487 | $-7,398 | $-993 | $24,000 | $-620 |
| Free Cash Flow | |||||
| Operating Cash Flow | -8,765 | -31,631 | -19,782 | -24,135 | -11,864 |
| Capital Expenditure | -130 | -1,201 | -990 | -554 | -455 |
| Free Cash Flow | -8,895 | -32,832 | -20,772 | -24,689 | -12,319 |